145 related articles for article (PubMed ID: 37391408)
21. Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.
Siddharth S; Parida S; Muniraj N; Hercules S; Lim D; Nagalingam A; Wang C; Gyorffy B; Daniel JM; Sharma D
Elife; 2021 Dec; 10():. PubMed ID: 34889737
[TBL] [Abstract][Full Text] [Related]
22. SIPL1, Regulated by MAZ, Promotes Tumor Progression and Predicts Poor Survival in Human Triple-Negative Breast Cancer.
He J; Wang J; Li T; Chen K; Li S; Zhang S
Front Oncol; 2021; 11():766790. PubMed ID: 34976812
[TBL] [Abstract][Full Text] [Related]
23. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer.
Zhai S; Lin J; Ji Y; Zhang R; Zhang Z; Cao Y; Liu Y; Tang X; Liu J; Liu P; Lin J; Li F; Li H; Shi Y; Fu D; Deng X; Shen B
Cell Discov; 2023 Sep; 9(1):95. PubMed ID: 37714834
[TBL] [Abstract][Full Text] [Related]
24. The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells.
Pamarthy S; Jaiswal MK; Kulshreshtha A; Katara GK; Gilman-Sachs A; Beaman KD
Oncotarget; 2015 Oct; 6(33):34206-20. PubMed ID: 26418877
[TBL] [Abstract][Full Text] [Related]
25. ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc.
Cheng Y; Lin L; Li X; Lu A; Hou C; Wu Q; Hu X; Zhou Z; Chen Z; Tang F
Cancer Cell Int; 2021 Jan; 21(1):32. PubMed ID: 33413403
[TBL] [Abstract][Full Text] [Related]
26. EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress.
Zhang R; Li X; Liu Z; Wang Y; Zhang H; Xu H
Cancer Cell Int; 2020; 20():175. PubMed ID: 32477007
[TBL] [Abstract][Full Text] [Related]
27. TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway.
Liu W; Chen G; Sun L; Zhang Y; Han J; Dai Y; He J; Shi S; Chen B
Front Oncol; 2019; 9():617. PubMed ID: 31338333
[No Abstract] [Full Text] [Related]
28. Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer.
Zhu H; Bhaijee F; Ishaq N; Pepper DJ; Backus K; Brown AS; Zhou X; Miele L
Am J Cancer Res; 2013; 3(2):230-9. PubMed ID: 23593544
[TBL] [Abstract][Full Text] [Related]
29. Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins.
Zhang M; Meng M; Liu Y; Qi J; Zhao Z; Qiao Y; Hu Y; Lu W; Zhou Z; Xu P; Zhou Q
Breast Cancer Res; 2021 Dec; 23(1):116. PubMed ID: 34922602
[TBL] [Abstract][Full Text] [Related]
30. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis.
Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
Cancer Cell Int; 2020; 20():454. PubMed ID: 32944002
[TBL] [Abstract][Full Text] [Related]
31. NDC80 Enhances Cisplatin-resistance in Triple-negative Breast Cancer.
Li J; Xu X; Peng X
Arch Med Res; 2022 Jun; 53(4):378-387. PubMed ID: 35346500
[TBL] [Abstract][Full Text] [Related]
32. TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway.
Liu W; Han J; Shi S; Dai Y; He J
Cancer Cell Int; 2019; 19():242. PubMed ID: 31572059
[TBL] [Abstract][Full Text] [Related]
33. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
34. FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells.
Hamurcu Z; Delibaşı N; Nalbantoglu U; Sener EF; Nurdinov N; Tascı B; Taheri S; Özkul Y; Donmez-Altuntas H; Canatan H; Ozpolat B
J Mol Med (Berl); 2019 Apr; 97(4):491-508. PubMed ID: 30729279
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
[TBL] [Abstract][Full Text] [Related]
36. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
Shen H; Yan W; Yuan J; Wang Z; Wang C
J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
[TBL] [Abstract][Full Text] [Related]
38. A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy.
Qiao Z; Li X; Kang N; Yang Y; Chen C; Wu T; Zhao M; Liu Y; Ji X
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823477
[TBL] [Abstract][Full Text] [Related]
39. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication.
Sheng X; Dai H; Du Y; Peng J; Sha R; Yang F; Zhou L; Lin Y; Xu S; Wu Y; Yin W; Lu J
J Exp Clin Cancer Res; 2021 Jun; 40(1):205. PubMed ID: 34162418
[TBL] [Abstract][Full Text] [Related]
40. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
